Literature DB >> 35054198

18F-FDG PET/CT in a Case of Urothelial Carcinoma in the Urachus Presenting as Colon Cancer.

Jeannette D Andersen1,2, Knud Fabrin3, Astrid Petersen4, Helle D Zacho1,2.   

Abstract

Urachal cancer arises from an embryologic remnant of the urogenital sinus and allantois and accounts for approximately 1% of bladder malignancies. The most encountered histologic subtype is adenocarcinoma. We present a 76-year-old man suspected to have an advanced sigmoid cancer infiltrating nearby organs. A supplemental 18F-FDG PET/CT showed high tracer uptake in a tumorous process coherent with the dome of the bladder wall involving the sigmoid colon. Cystoscopy revealed a normal bladder wall, except for a small edematous area in the anterior bladder. Biopsies from the sigmoid colon and transurethral resection from the bladder confirmed a urothelial carcinoma originating from the urachus.

Entities:  

Keywords:  18F-FDG PET/CT; urachal cancer; urothelial carcinoma

Year:  2021        PMID: 35054198      PMCID: PMC8774599          DOI: 10.3390/diagnostics12010031

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


We present a 76-year-old man initially suspected to have an advanced colon cancer infiltrating nearby organs including the bladder and small intestines. During colonoscopy, the operator describes an ulcerating tumor in the sigmoid colon occupying more than half of the circumference. Surprisingly, the biopsies revealed a urothelial carcinoma. A supplemental 18F-FDG PET/CT conducted as part of the Danish standard-of-care for staging of muscle invasive bladder cancer was conducted along with a cystoscopy [1,2]. The maximum intensity projection of the 18F-FDG PET/CT image in the anterior view (A) revealed a high tracer uptake in an infiltrating tumorous mass coherent with the top of the bladder (full arrows) and an enlarged metastatic lymph node with high tracer uptake (dotted red arrow) in the upper right abdomen. In the sagittal view of the fused 18F-FDG PET/CT image (B) and low-dose CT (C), the coherence of the tumor to the top of the bladder wall stretching along the urachus is elegantly illustrated, supporting the suspicion of a urachal cancer. The tumor infiltrates the peritoneum, small intestines and sigmoid colon. The intestinal involvement is apparent in the coronal fused 18F-FDG PET/CT image (D) and coronal low dose CT (E), which shows the tumor (full arrows) and lymph node metastasis (dotted arrow). The cystoscopy revealed no visible tumors and a normal bladder wall. However, a small area in the top of the anterior bladder wall looked edematous. A small transurethral resection of 3 ml tissue from this area fulfilled the criteria for the diagnosis of urothelial carcinoma, high-grade, originating from the urachus, except that no urachus remnants were found in the specimen [3]. The stage according to the Sheldon Classification [4] was IVA and according to the TNM 8th Edition [5] and TNM Supplement 5th Edition [6] pT4a. Two histopathological images of urothelial carcinoma, H&E, low magnification (A), and GATA3, high magnification (B). Urachal cancer is a rare entity which accounts for 0.5–2% of bladder cancer [7] and most urachal malignancies represents an adenocarcinoma [7,8,9,10,11,12]. According to Reis et al, 58 cases have been reported during the last [6,7] decades, representing a urothelial carcinoma [13]. We present a case of an unusual presentation of the disease which illustrates how an 18F-FDG PET/CT elegantly complements the diagnosis and staging. Due to the infiltrating tumorous growth involving the sigmoid colon, small intestines and lymph node metastases no primary tumor resection was performed. The patient was offered palliating oncologic treatment.
  11 in total

1.  Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up.

Authors:  Stefan Vind-Kezunovic; Kirsten Bouchelouche; Pia Ipsen; Søren Høyer; Cathrine Bell; Jørgen Bjerggaard Jensen
Journal:  Eur Urol Focus       Date:  2017-06-23

Review 2.  18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.

Authors:  Sarah M H Einerhand; Erik J van Gennep; Laura S Mertens; Kees Hendricksen; Maarten L Donswijk; Henk G van der Poel; Bas W G van Rhijn
Journal:  Curr Opin Urol       Date:  2020-09       Impact factor: 2.309

3.  Urachal carcinoma: Report of two cases and review of the literature.

Authors:  Jing Quan; Xiang Pan; Lu Jin; Tao He; Jia Hu; Bentao Shi; Jian Peng; Zhebo Chen; Shangqi Yang; Xiangming Mao; Yongqing Lai
Journal:  Mol Clin Oncol       Date:  2016-11-16

Review 4.  Malignant urachal lesions.

Authors:  C A Sheldon; R V Clayman; R Gonzalez; R D Williams; E E Fraley
Journal:  J Urol       Date:  1984-01       Impact factor: 7.450

5.  Prognostic factors in urachal adenocarcinoma. A study in 41 specimens of DNA status, proliferating cell-nuclear antigen immunostaining, and argyrophilic nucleolar-organizer region counts.

Authors:  K Nakanishi; T Kawai; M Suzuki; C Torikata
Journal:  Hum Pathol       Date:  1996-03       Impact factor: 3.466

6.  Urachal carcinoma.

Authors:  D E Johnson; G B Hodge; F W Abdul-Karim; A G Ayala
Journal:  Urology       Date:  1985-09       Impact factor: 2.649

Review 7.  Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.

Authors:  Gladell P Paner; Antonio Lopez-Beltran; Deepika Sirohi; Mahul B Amin
Journal:  Adv Anat Pathol       Date:  2016-03       Impact factor: 3.875

8.  Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis.

Authors:  Giulio Riva; Christine Mian; Claudio Luchini; Ilaria Girolami; Claudio Ghimenton; Luca Cima; Luca Novelli; Esther Hanspeter; Guido Mazzoleni; Christine Schwienbacher; Stefan Pycha; Carolina D'Elia; Emanuela Trenti; Armin Pycha; Guido Martignoni; Ondrej Hes; Albino Eccher; Gabriella Nesi; Matteo Brunelli
Journal:  Virchows Arch       Date:  2018-10-09       Impact factor: 4.064

9.  Investigating urachal carcinoma for more than 15 years.

Authors:  Duqun Chen; Yifan Li; Zuhu Yu; Zhengming Su; Liangchao Ni; Yaoting Gui; Shangqi Yang; Bentao Shi; Yongqing Lai
Journal:  Oncol Lett       Date:  2014-09-04       Impact factor: 2.967

Review 10.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.